Hugo Harrod

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.

Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.

SkyCell offers a data-driven container solution that allows pharma companies to optimise their supply chain by reducing, and even predicting, the risk of delivering sensitive drugs by air. It brings together big data, software and hardware to transform an ever-evolving supply chain, using a growing pool of nearly one billion data-points to enable a market-leading failure rate of less than 0.1%, whilst also reducing CO2 emissions by almost half. Founded in Switzerland in 2012, the company’s innovative approach has been validated by leading pharma companies and has partnerships with major airlines. For more information visit www.skycell.ch

Founded in 2004, eZono AG is a different kind of ultrasound company, one that empowers non-traditional ultrasound users to incorporate sonography in their daily work. This enables our customers to improve clinical outcomes, enhance patient satisfaction and in particular lower cost. As a result we bring not only affordable portable sonography technology to specific applications but also makes it easy for instance for anesthetists to operate - reducing drastically their learning effort. Investment demands and learning requirements have kept sonography in only well-defined clinical niches far too long. By empowering sonography, eZono breaks into new applications for ultrasound imaging like regional anesthesia. Only few regional anesthesia procedures are supported by ultrasound imaging today, the rest are done ‘blindly’ which result in patient anxiety, pain, cost and risk. With our eZono™ 3000 system designed for regional anesthesia, sonography becomes a standard tool for anaesthetists. The eZono® 4000, is eZono’s flagship product, offering unique solutions to address the real life challenges facing clinicians every day, when using ultrasound at the point of care. Using the latest technology to provide advanced functionality with the simplicity and reliability requested and required by clinicians providing point of care services, the eZono® 4000 represents a new era of imaging, needle guidance and education, at a price point reflecting the needs of healthcare providers worldwide. eZono - We Guide You

Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine. With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate, or permanently alter, the function of almost any gene in human and other mammalian cell lines. Horizon is headquartered in Cambridge, UK with offices in USA and Japan.

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.

At Gynesonics our mission is to design and develop new and advanced technologies for improving women’s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. If your post, comment or message references an adverse event with the Sonata Treatment, we may contact you for more information. To monitor the safety of our products, we encourage you to report suspected adverse effects by calling Gynesonics at 844-723-5382 Monday – Friday 9 AM – 5 PM EST. Alternatively, you can report any serious side effects directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. We are committed to responding to your messages promptly. Our regular business hours are [Monday – Friday 9 AM – 5 PM EST. If a message is sent or a comment is made outside of regular business hours, or on weekends or company holidays, we will respond when business resumes. Please call 911 in the event of an emergency.

Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.

SkyCell offers a data-driven container solution that allows pharma companies to optimise their supply chain by reducing, and even predicting, the risk of delivering sensitive drugs by air. It brings together big data, software and hardware to transform an ever-evolving supply chain, using a growing pool of nearly one billion data-points to enable a market-leading failure rate of less than 0.1%, whilst also reducing CO2 emissions by almost half. Founded in Switzerland in 2012, the company’s innovative approach has been validated by leading pharma companies and has partnerships with major airlines. For more information visit www.skycell.ch